BioNTech SE vs UnitedHealth Group Incorporated — Stock Comparison
Q·Score Breakdown
4.6
Underperform
Overall
6.3
Hold
Quality
Health
Growth
Valuation
Sentiment
BNTX
Clean balance sheet with low leverage (0.0× debt-to-equity).
⚠ currently unprofitable (-40% margin).
UNH
82% of 28 covering analysts rate it Buy or Strong Buy.
⚠ limited growth momentum.
Analyst Consensus
BUY
Target $130.86 (+25.5%)
18 analysts
BUY
Target $387.27 (+5.1%)
26 analysts
Fundamentals
BNTX
UNH
—
Trailing P/E
27.8×
-23.3×
Forward P/E
17.8×
-39.6%
Profit Margin
2.7%
78.7%
Gross Margin
18.8%
-5.9%
ROE
12.2%
-23.7%
Revenue Growth
2.0%
—
Earnings Growth
0.7%
1.59
Beta
0.41
—
Price / Book
—
$26.4B
Market Cap
$334.6B
$80 – $124
52-Week Range
$235 – $412
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.